Zachary joined the Burnet in 2023 as a student and finished the year as a Research Assistant for the Alcohol and other Drugs team.
He previously worked at an alcohol and other drug treatment site which instilled in him his passion for harm reduction initiatives and their potential for mitigating the adverse harms associated with illicit substance use. This work experience prompted him to undertake an Honours degree in Biomedical Science with Monash University, where he completed a thesis exploring Australian attitudes towards supervised injecting facilities in 2023.
Drug and Alcohol Review
Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh, Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh
Drug and Alcohol Review
Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh, Zachary Lloyd, Samantha Colledge‐Frisby, Nicholas Taylor, Michael Livingston, Amanda Roxburgh
BMJ Open
Dylan Vella-Horne, Ashleigh C. Stewart, Matthew Hickman, Paul A. Agius, Nick Scott, Amanda Roxburgh, Daniel O’Keefe, Peter Higgs, Mark Stoové, Zachary Lloyd
MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.
The VMAX cohort study follows 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.
The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).